Limei Qu
- Oncology top 10%
-
- Cancer Genomics and Diagnostics 5
- Hepatology top 10%
-
- Brain Metastases and Treatment 7
-
- Glioma Diagnosis and Treatment 12
-
- Meningioma and schwannoma management 10
-
- Cerebrospinal fluid and hydrocephalus 6
-
- Vascular Malformations Diagnosis and Treatment 6
-
- Pituitary Gland Disorders and Treatments 5
-
- Pancreatitis Pathology and Treatment 4
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Medicine (6 papers)World Journal of Surgical Oncology (5 papers)International Journal of Medical Sciences (3 papers)
- Partner nations
- ChinaUnited StatesSlovakia
In The Last Decade
Limei Qu
60 papers receiving 908 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 333
- Immunology 199
- Cancer Research 133
- Hepatology 70
- Pulmonary and Respiratory Medicine 280
Countries citing papers authored by Limei Qu
This map shows the geographic impact of Limei Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Qu more than expected).
Fields of papers citing papers by Limei Qu
This network shows the impact of papers produced by Limei Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Qu. The network helps show where Limei Qu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Limei Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 7 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 7 | |
| 12 | 2019 | 1 | |
| 13 | 2019 | 1 | |
| 14 | Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancerbreakdown → | 2018 | 361 |
| 15 | 2015 | 29 | |
| 16 | 2014 | 2 | |
| 17 | 2013 | 2 | |
| 18 | 2012 | 16 | |
| 19 | 2012 | 11 | |
| 20 | 2011 | 16 |
About Limei Qu
Limei Qu is a scholar working on Genetics, Otorhinolaryngology, Neurology, Oncology and Epidemiology, having authored 65 papers that have together received 917 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), Meningioma and schwannoma management (10 papers), Brain Metastases and Treatment (7 papers), Cerebrospinal fluid and hydrocephalus (6 papers), Vascular Malformations Diagnosis and Treatment (6 papers), Pituitary Gland Disorders and Treatments (5 papers), Cancer Genomics and Diagnostics (5 papers) and Pancreatitis Pathology and Treatment (4 papers). The work is most often cited by research in Oncology (333 citations), Immunology (199 citations), Cancer Research (133 citations), Hepatology (70 citations) and Pulmonary and Respiratory Medicine (280 citations). Limei Qu has collaborated with scholars based in China, United States and Slovakia. Frequent co-authors include Sisi Wang, Li Zhang, Wei Liu, Hao Xu, Dalam Ly, Jinlu Yu, Kan Xu, Runping Gao, Li Sun and Xueyuan Cao. Their work appears in journals such as Medicine, World Journal of Surgical Oncology, International Journal of Medical Sciences, World Neurosurgery and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.